About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
March 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter List
Legislative Tracking Tools
Category Archives: Podcast
A Conversation with Dr. David Kessler, Former FDA Commissioner
Last week, my employer – Fleishman-Hillard, held a public affairs briefing in Washington, D.C. that included several of the members of the International Advisory Board (IAB) for the firm. The event was co-hosted by the Capitol Hill newspaper Roll Call … Continue reading
Posted in Podcast
3 Comments
Does Cholesterol Matter? A Conversation with John Carey of BusinessWeek
Every time I hear the sound of my recorded voice, I am reminded why I write so much. I am still quite rough at the edges. Nevertheless, I’ve had the courage to do another podcast, this time with John Carey, … Continue reading
Dr. David Acheson
Last week, I had the good fortune to sit down with Dr. David Acheson, Assistant Commissioner for Food Safety at the Food and Drug Administration. I had wanted to meet him ever since reading about him in the Washington Post … Continue reading
Posted in Podcast
Comments Off on Dr. David Acheson
A Conversation with Jim Greenwood – BIO CEO and President
The newly passed legislation in Congress that will reform FDA and reauthorize the Prescription Drug User Fee Act for another five years is just one example of dynamic change that is occurring in the marketplace. This week, I was able … Continue reading
Posted in Podcast
Comments Off on A Conversation with Jim Greenwood – BIO CEO and President
A Conversation with Pill Book Editor – Dr. Harold Silverman
I had occasion to have a conversation with Dr. Harold Silverman, editor of The Pill Book – a perennially popular resource for consumers to learn about the medicines they are taking, now in its 12th edition. We of course talked … Continue reading